Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 55 M54 M54 M56 M58 M57 M 225 M Research & development —————— — Operating income 339 M359 M379 M367 M374 M384 M 1.5 B Non-Operating Income, Total 5 M4 M4 M10 M4 M5 M 23 M Interest expense, net of interest capitalized 236 M235 M237 M222 M210 M212 M 881 M Non-Operating Income, excl. Interest Expenses -231 M-231 M-233 M-212 M-206 M-207 M -858 M Unusual income/expense —————— — Pretax income 148 M166 M190 M165 M174 M188 M 717 M Equity in earnings 1 M2 M1 M—1 M2 M — Taxes 31 M36 M40 M-3 M37 M39 M 113 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 117 M130 M150 M168 M137 M149 M 604 M Discontinued operations —————— — Net income 117 M130 M150 M168 M137 M149 M 604 M Dilution adjustment 0000—— — Preferred dividends 0000—— — Diluted net income available to common stockholders 117 M130 M150 M168 M137 M149 M 604 M Basic earnings per share (Basic EPS) 0.320.360.410.480.380.42 1.69 Diluted earnings per share (Diluted EPS) 0.320.360.410.470.380.42 1.68 Average basic shares outstanding 361.73 M361.42 M360.56 M360.84 M359.49 M356.57 M — Diluted shares outstanding 363.07 M362.26 M361.67 M361.95 M360.23 M357.41 M — EBITDA ———161 M—— — EBIT 103 M124 M142 M145 M164 M172 M 623 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) ———16 M—— —